Physician

Abdul Qadir, M.D.

According to 2025 Medicare claims, Abdul Qadir, M.D. (NPI: 1902809742) practices pain management in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is REGIONAL PAIN CARE PC (NPI: 1659640589; TIN: 452374469) and primary practice location at 08232-9998.

Qadir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 111 traditional Medicare patients, billed 1,139 HCPCS/CPT codes, and received $96,055 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,030 prescription claims across 198 beneficiaries totaling $408,347 in drug costs, led by Oxycontin (Oxycodone Hcl). 2018 DME data shows 96 claims. Open Payments data shows 29 records totaling $709. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $135,406 and ending at $96,055. Concurrently, Part D prescription costs have risen steadily, from $268,202 to $408,347. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $19,890 and ending at $8,096.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	339	2,120	$135,406
2016	330	1,806	$113,497
2017	317	1,968	$118,788
2018	346	2,606	$152,227
2019	332	2,694	$152,168
2020	209	1,694	$93,071
2021	176	1,267	$80,653
2022	162	1,714	$126,955
2023	137	1,351	$105,437
2024	111	1,139	$96,055

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	304	2,703	$268,202
2016	292	2,016	$194,678
2017	302	1,729	$120,339
2018	335	2,122	$176,031
2019	358	2,355	$207,810
2020	276	2,402	$263,707
2021	302	2,834	$293,499
2022	278	2,550	$309,736
2023	242	2,638	$352,866
2024	198	2,030	$408,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	42	72	$6,619
2016	35	160	$13,404
2017	13	74	$4,639
2018	13	96	$10,075
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	88	519	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	81	388	$69
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	11	19	$62
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	14	74	$52
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	13	69	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	94	2,780	$53,840
Xtampza Er	Oxycodone Myristate	47	1,395	$20,617
Linzess	Linaclotide	21	990	$17,226
Ubrelvy	Ubrogepant	16	300	$16,267
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	406	10,550	$11,857

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$709	Collegium Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Qadir, M.D.?

Tedicare shows public-source Medicare data for Abdul Qadir, M.D. (NPI 1902809742), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Qadir, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul Qadir, M.D.?

Abdul Qadir, M.D. is linked to REGIONAL PAIN CARE PC (billing NPI 1659640589) in the available physician profile data.

Does Abdul Qadir, M.D. have Open Payments data?

Abdul Qadir, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.